Filing Flows › Teva Pharmaceutical Industries (TEVA) › Distribution revenue
Teva Pharmaceutical Industries (TEVA) Distribution revenue by quarter
Teva Pharmaceutical Industries' Distribution revenue was $421M in Q3 2026 (third quarter 2026), -3% from Q2 2026. Over the last 7 quarters it ranged from $377M (Q2 2025) to $433M (Q2 2026).
| Quarter | Distribution revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $421M | -3% | +4% |
| Q2 2026 | $433M | +9% | +15% |
| Q1 2026 | $396M | +3% | +3% |
| Q4 2025 | $384M | -5% | — |
| Q3 2025 | $406M | +8% | — |
| Q2 2025 | $377M | -2% | — |
| Q1 2025 | $384M | — | — |
Q3 2026 at a glance
Teva Pharmaceutical Industries, Q3 2026: revenue $4.4B (-2% year over year), operating margin 16.2%, net earnings $234M, operating cash flow $241M. The chart follows the revenue to costs, profit and cash.
Questions
What is Teva Pharmaceutical Industries' Distribution revenue?
Teva Pharmaceutical Industries' Distribution revenue was $421M in Q3 2026 (third quarter 2026), -3% from Q2 2026.
How has Teva Pharmaceutical Industries' Distribution revenue changed?
Over the last 7 quarters it ranged from $377M (Q2 2025) to $433M (Q2 2026).
Q3 2026 results → · How Teva Pharmaceutical Industries makes money →